304 results on '"Sanders, Andrew J."'
Search Results
2. Retraction Note: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
3. RETRACTED ARTICLE: Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
4. Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
5. Electrophysiological evidence of heterogeneity in visual statistical learning in young children with ASD
6. Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives
7. ALCAM, Activated Leukocyte Cell Adhesion Molecule, in Clinical Gastric Cancer and Patient’s Response to Chemotherapies
8. Abstract P2-11-33: Striatin and its interactive proteins Protein Phosphatase-2 (PP2) and PP2 regulatory elements in breast cancer
9. Abstract P6-14-17: Endomucins and their expression in breast cancer and the cellular and therapeutic impact
10. Abstract P3-05-42: Identification of subpopulation of breast cancer patients with poor clinical outcome using CUB domain containing protein-1 (CDCP1)/CD318 and its interactive proteins SRC and the HGF axis
11. Abstract P6-12-01: ALCAM (Activated Leukocyte Cell Adhesion Molecule) is associated with HGF/MET signalling pathway in different subtypes of breast cancer
12. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
13. Long Non-Coding RNAs in Cancer Progression: Implication for Anti-Cancer Therapy
14. nWASP Inhibition Increases Wound Healing via TrKb/PLCγ Signalling
15. Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers
16. Transglutaminase-4 (Prostate Transglutaminase), a Potential Biological Factor and Clinical Indicator for the Diagnosis and Prognosis of Prostate Cancer
17. EPLIN, a Putative Tumour Suppressor in Colorectal Cancer, Implications in Drug Resistance
18. A stream insect detritivore violates common assumptions of threshold elemental ratio bioenergetics models
19. ECIS as a Tool in the Study of Metastasis Suppressor Genes: Epithelial Protein Lost In Neoplasm (EPLIN)
20. Electric Cell-Substrate Impedance Sensing as a Screening Tool for Wound Healing Agents
21. Psoriasin (S100A7) is a positive regulator of survival and invasion of prostate cancer cells
22. EPLIN: a fundamental actin regulator in cancer metastasis?
23. Overexpressed transient receptor potential vanilloid 1 (TRPV1) in lung adenocarcinoma harbours a new opportunity for therapeutic targeting
24. Activated leukocyte cell adhesion molecule (ALCAM)/CD166 in pancreatic cancer, a pivotal link to clinical outcome and vascular embolism
25. Hepatitis A Virus Cellular Receptor 1 (HAVcr-1) Initiates Prostate Cancer Progression in Human Cells via Hepatocyte Growth Factor (HGF)-Induced Changes in Junctional Integrity
26. EPLIN is a Negative Regulator of Prostate Cancer Growth and Invasion
27. Sensitivity of the Wound Edge Gene Signature “WD14” in Responding to Clinical Change: A Longitudinal Cohort Study
28. Silencing CTNND1 Mediates Triple-Negative Breast Cancer Bone Metastasis via Upregulating CXCR4/CXCL12 Axis and Neutrophils Infiltration in Bone
29. PTH-100 DAP3 and the DAP3 Binding Cell Death Enhancer-1 (DELE1) in human colorectal cancer
30. PTH-82 Alcam, activated leukocyte cell adhesion molecule, in clinical gastric cancer
31. OTU-17 Expression, clinical and prognostic value of dual specific protein phosphatase-7 (DUSP-7) in pancreatic cancer
32. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
33. WAVE3 is associated with invasiveness in prostate cancer cells
34. Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in Cancers
35. YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells
36. Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo
37. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer
38. EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
39. HGF/SF up-regulates the expression of bone morphogenetic protein 7 in prostate cancer cells
40. The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis
41. ECIS as a Tool in the Study of Metastasis Suppressor Genes: Epithelial Protein Lost In Neoplasm (EPLIN)
42. Electric Cell-Substrate Impedance Sensing as a Screening Tool for Wound Healing Agents
43. Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration
44. Hepatocyte Growth Factor is a Potential Lymphangiogenic Factor; Clinical Implications
45. Indexing Early Visual Memory Durability in Infancy
46. Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination
47. WAVE1 is Associated With Invasiveness and Growth of Prostate Cancer Cells
48. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro
49. Tumour endothelial marker-8 in wound healing and its impact on the proliferation and migration of keratinocytes
50. Indexing Early Visual Memory Durability in Infancy.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.